Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000242953 encodes a pseudogene that is similar to a segment of the ankyrin repeat domain 36 (ANKRD36) gene. Pseudogenes are genomic sequences that closely resemble known genes but are typically unable to encode functional proteins due to disruptive mutations such as frameshifts or premature stop codons. While pseudogenes may occasionally transcribe noncoding RNAs with potential gene regulatory roles, there is no established functional protein or direct therapeutic relevance for this pseudogene. As a result, it is not considered a target for pharmacological intervention, nor is it implicated directly in disease, though pseudogenes as a class can play regulatory roles in rare cases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of ankyrin repeat domain 36.